Skip to main content

Table 3 MAP (mmHg) follow-up in the two study groups

From: The value of local dexmedetomidine as an adjuvant to ultrasound-guided wide awake local anesthesia no tourniquet (WALANT) in flexor tendon repair surgeries: a randomized controlled trial

MAP (mmHg)

Group D (n = 64)

Group C (n = 64)

95% CI

P

Basal

95.89 ± 6.515

94.98 ± 6.975

-1.45, 3.27

0.449

10 min

94.58 ± 8.587

92.83 ± 10.542

-1.62, 5.12

0.305

20 min

96.19 ± 9.053

92.64 ± 11.707

-0.11, 7.21

0.057

30 min

95.64 ± 9.918

93.08 ± 11.871

-1.26, 6.39

0.187

45 min

95.74 ± 9.495

92.49 ± 11.267

-1.17, 7.67

0.148

60 min

96.55 ± 8.319

91.63 ± 10.730

-0.61, 10.43

0.080

  1. Data are presented as mean ± standard deviation
  2. Group D Patients injected with dexmedetomidine plus lidocaine/ epinephrine), group C Patients injected only with lidocaine/ epinephrine
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us